This article refers to:
Correction to: The pharmacokinetics and clinical efficacy of AVP-825: a potential advancement for acute treatment of migraine.
Cady R. The pharmacokinetics and clinical efficacy of AVP-825: a potential advancement for acute treatment of migraine. Expert Opin Pharmacother. 2015;16(13):2039-51.
Following publication of this article, errors have been identified in figures 2, 3 and 6. The corrected figures along with their legends are given below:
Figure 2. Headache relief post-dose (TARGET study).
Figure 3. Headache pain free post-dose (TARGET study).
Figure 6. Migraine-associated symptoms (COMPASS study) of (A) Nausea (B) Photophobia and (C) Phonophobia.
